Tseng Ying Lung, Hsu Hau-Ren, Kuo Fang-Hsin, Shieh Min-Hua, Chang Chin-Feng
Institute of Pharmacology and Toxicology, Doping Control Center, Tzu Chi University, Hualien, Taiwan.
J Anal Toxicol. 2003 Sep;27(6):359-65. doi: 10.1093/jat/27.6.359.
Ephedrine (EPH), pseudoephedrine (PEPH), phenylpropanolamine (PPA), and methylephedrine (MEPH) are ephedrine alkaloids commonly found in cold medications and are banned by the International Olympic Committee (IOC). These compounds were detected in the urinary doping tests during the national sport competitions in Taiwan. To study the sources of these compounds, 91 over-the-counter (OTC) nonprescription cold remedies, along with 1803 athletes' urine samples collected (from 1999 to 2001) in competitions were analyzed using gas chromatography-nitrogen-phosphorus detection (GC-NPD) for initial screening and GC-mass spectrometry (MS) for confirmation. We found that 80% of OTC cold medicines showed banned ephedrines in their ingredients lists, in which MEPH (52%) was the most common drug labeled. However, when these OTC cold medicines were analyzed by GC-NPD and GC-MS, EPH (35.4%) was found substantially higher than that labeled in the OTC products (1.3%). In the total urine specimens tested, approximately 2.8% contained banned ephedrines and 1.3% exceeded the IOC cutoff levels. Within the urine specimens that exceeded the IOC cutoff values, PEPH accounted for a 44% occurrence rate, followed by EPH (28%), PPA (17%), and MEPH (11%). In agreement with the other report, bodybuilders showed a high incidence rate for ephedrines misuse. Nevertheless, it is likely that the high incidence of doping violations for ephedrine-related substances was related to misuse of ephedrines present in most OTC common cold medicines and some dietary supplements for relieving cold symptoms, reducing body weight, and preserving muscle.
麻黄碱(EPH)、伪麻黄碱(PEPH)、苯丙醇胺(PPA)和甲基麻黄碱(MEPH)是常见于感冒药中的麻黄碱类生物碱,被国际奥委会(IOC)禁止使用。在台湾的全国体育比赛中,这些化合物在尿液兴奋剂检测中被检出。为了研究这些化合物的来源,使用气相色谱-氮磷检测(GC-NPD)进行初步筛查,并采用气相色谱-质谱联用(GC-MS)进行确证,对91种非处方(OTC)感冒药物以及1803份(1999年至2001年)运动员比赛期间收集的尿液样本进行了分析。我们发现,80%的OTC感冒药在其成分列表中显示含有被禁用的麻黄碱类物质,其中甲基麻黄碱(52%)是最常见的标注药物。然而,当对这些OTC感冒药进行GC-NPD和GC-MS分析时,发现麻黄碱(35.4%)的含量大大高于OTC产品标注的含量(1.3%)。在检测的全部尿液样本中,约2.8%含有被禁用的麻黄碱类物质,1.3%超过了国际奥委会的临界值。在超过国际奥委会临界值的尿液样本中,伪麻黄碱的出现率为44%,其次是麻黄碱(28%)、苯丙醇胺(17%)和甲基麻黄碱(11%)。与其他报告一致,健美运动员中麻黄碱类物质滥用的发生率较高。然而,与麻黄碱相关物质的兴奋剂违规高发生率很可能与大多数OTC普通感冒药和一些用于缓解感冒症状、减轻体重及保持肌肉的膳食补充剂中存在的麻黄碱类物质滥用有关。